Author:
Dengler R.,Plewan A.,Suss C.,Busch R.,Eger G.,Emmerich B.
Publisher
Springer Berlin Heidelberg
Reference19 articles.
1. Schiffer C.A., E.J. Lee, T. Tomiyasu, P.H. Wiernik, J.R. Testa (1989) Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemia, Blood 73, 263–270.
2. Büchner Th., W. Hiddemann, B. Wörmann, A. Heinecke, M.C. Sauerland, D.R. Fonatsch, Beacher, D. Hosfeld, J. Goasguen, H. Löffler, U.W. Schäfer for the German AML Cooperative Group (1993) Factors determining outcome in patients with AML (Abstract), Blood 82 (Suppl.), 1929.
3. Löwenberg B. (1995) Post-remission treatment of acute myelogenous leukemia, N. Engl. J. Med. 332, 260–262.
4. Ellison R.R. (1982) Acute myelocytic leukemia, In: Holland J.F. and Frei E. (Eds.), Cancer Medicine, pp. 1407–1446, Philadelphia, Lea & Febiger.
5. Heinecke A., M.C. Sauerland, and Büchner Th. (1990) Predictive models for achievement of complete remission and duration of first remission in adult myeloid leukemia, In: Büchner Th., Schellong G., Hiddemann W., and Ritter J. (Eds.), Acute Leukemias II, Haematology and Blood Transfusion, 33, pp. 285–289, Berlin, Springer.